Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2018-11-15

Original market date: See footnote 1

2004-08-12

Product name:

OXYTROL

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02254735

Product Monograph/Veterinary Labelling:

Date: 2018-03-16 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

ALLERGAN INC
500  85 Enterprise Blvd
Markham
Ontario
Canada  L6G 0B5

Class: 

Human

Dosage form(s):

Patch

Route(s) of administration:

Transdermal

Number of active ingredient(s):

1

Schedule(s):

Prescription  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

86:12.04   Antimuscarinics

Anatomical Therapeutic Chemical (ATC): See footnote 4

G04BD04  OXYBUTYNIN

Active ingredient group (AIG) number:See footnote 5

0150161002

List of active ingredient(s)
Active ingredient(s) Strength
OXYBUTYNIN 3.9 MG / 24 HOUR

Application information

Related information

Contact us

Version 3.9.0
Date modified: